United States Pharmaceutical Sterility Testing Market to 2025 - Supportive Government Investment in the Healthcare Industry Driving the $700+ Million Market
DUBLIN, Nov. 7, 2018 /PRNewswire/ --
The "U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourced), By Test Type (Bacterial Endotoxin, Sterility), By End Use, By Sample, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The U.S. pharmaceutical sterility testing market size is expected to reach USD 713.6 million by 2025 and is anticipated to expand at a CAGR of 11.3% over the forecast period.
Supportive government investment in healthcare industry, increasing R&D activities, and drug launches are the key factors driving market growth.
The government is keen on bringing down healthcare costs which is anticipated to encourage the U.S. Food and Drug Administration (FDA) to promote fast approvals of generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods. This is anticipated to encourage market participants to spend more on sterility solutions and in turn, expand the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, and indication. These launches require thorough sterility testing and thus, are anticipated to drive market growth.
On the basis of type, the U.S. pharmaceutical sterility testing market is segmented into in-house and outsourcing. Most market players prefer outsourcing sterility testing services, as it is economically viable. Companies shortlist and select outsourcing firms based on their experience, expertise, and quality of service. Hence, it is difficult for new players to enter into this area.
Companies active in the U.S. pharmaceutical sterility testing market are Charles River Laboratories, Pace Analytical Series LLC, DynaLabs, Infinity, Boston Analytical, and others. Market players employ various growth strategies such as mergers, capacity expansion, and venturing into new regions.
For instance, in April 2018, Charles River Labs completed acquisition of MPI Research, a non-clinical Contract Research Organization (CRO) providing detailed services to medical device and biopharmaceutical companies. This acquisition is anticipated to expand biotechnology client base of the former and to provide the company access to MPI's scientific expertise and quality services.
Further key findings from the report suggest:
- U.S. pharmaceutical sterility testing market was valued at USD 302.2 million in 2017 and is expected to grow lucratively over the forecast period
- In terms of revenue, outsourcing segment is anticipated to grow at a lucrative rate during the forecast period.
- Sterility testing segment was valued at USD 97.6 million in 2016 and is anticipated to witness swift growth over the forecast period.
Key Topics Covered:
Chapter 1 Research Methodology
1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 U.S. Pharmaceutical Sterility Testing Market Snapshot
Chapter 3 U.S. Pharmaceutical Sterility Testing Market: Variables, Trends & Scope
3.1 U.S. Pharmaceutical Sterility Testing Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Supportive government investment in the healthcare industry
3.1.1.2 Increasing R&D activities
3.1.1.3 Increasing number of drug launches
3.1.1.4 Increasing focus on quality and sterility
3.1.2 Market Restraint Analysis
3.1.2.1 Third party performance
3.2 Penetration & growth prospect mapping
3.3 U.S. Pharmaceutical Sterility Testing Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's
Chapter 4 U.S. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis
4.1 U.S. pharmaceutical sterility testing market: Type movement analysis
4.2 In-house pharmaceutical sterility testing
4.2.1 In-house pharmaceutical sterility testing market, 2014 - 2025 (USD Million)
4.3 Outsourced pharmaceutical sterility testing
4.3.1 Outsourced pharmaceutical sterility testing market, 2014 - 2025 (USD Million)
Chapter 5 U.S. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis
5.1 U.S. pharmaceutical sterility testing market: Test type movement analysis
5.2 Sterility testing
5.3 Bioburden testing
5.4 Bacterial endotoxin testing
Chapter 6 U.S. Pharmaceutical Sterility Testing Market: End-use Estimates & Trend Analysis
6.1 U.S. pharmaceutical sterility testing market: End-use movement analysis
6.2 Compounding pharmacies
6.3 Medical device companies
6.4 Pharmaceutical companies
6.5 Others
Chapter 7 U.S. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis
7.1 U.S. pharmaceutical sterility testing market: Sample movement analysis
7.2 Sterility drugs
7.3 Medical devices
7.4 Biologics & therapeutics
Chapter 8 Regional Estimates & Trend Analysis, by Type, Test type, Sample, End-use
8.1 U.S. Pharmaceutical Sterility Testing Market 2014 & 2025
Chapter 9 Competitive Landscape
- Pacific Biolabs
- STERIS Corporation.
- Boston Analytical
- Gibraltar Laboratories
- Infinity Laboratories
- Dynalabs
- SGS SA
- Toxikon, Inc.
- Pace Analytical Services LLC
- Charles River Laboratories International, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/k5947s/united_states?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article